Navigation Links
Chronic Pain Patients Now Have Hope With Carryover Pain Relief Provided By Repeated Interferential Treatments
Date:2/16/2009

The Infrex Plus is now providing chronic pain patients the ability to self treat at home or work on an as needed basis. The surprising development is the amount of "carryover pain relief" most patients are achieving. Now interferential treatments are extending the residual pain relief period and reducing the overall pain levels for chronic pain patients offering better treatment options without the use of opioid drugs.

(PRWEB) February 16, 2009 -- The Infrex Plus is now providing chronic pain patients the ability to self treat at home or work on an as needed basis. The surprising development is the amount of "carryover pain relief" most patients are achieving.

Carryover pain relief, often referred to as "residual pain relief", is nothing more than the time period after the interferential treatment in which the patient has no pain. The phenomenon is not new to interferential for chronic pain patients, but to be able to self-treat as needed is opening new options for the chronic pain patient. " Interferential has been the leading clinical electrotherapy form of pain relief treatment since it's onset in 1951 primarily due to carryover pain relief", but only since November 2008 has the option been affordable and available to the chronic pain patient.

Historically interferential was only available to patients in a clinical setting. The patient would schedule an appointment and then come to the clinic or hospital for the 30 minute interferential treatment. The pain relief was immediate and the patient would leave the facility scheduling a return visit in anticipation of the return of the pain. The patient and clinician guessed how long it would be before the pain returned and the severity of the pain reached the point of needing treatment. In other words the "carryover pain period" was guessed at.

Today with the Infrex Plus the patient can treat as often as necessary whenever the pain returns. The carryover pain relief period is constantly extending from treatment to treatment. This is advancing the treatment of many historically chronic conditions such as:

·   Chronic Back Pain
·   Sciatica
·   Herniated Disc
·   Bulging Disc
·   Spinal Stenosis
·   Lumbar Pain
·   Osteoarthritis
·   Fibromyalgia Syndrome
·   Shingles
·   Phantom Limb Pain
·   Restless Leg Syndrome ( RLS)
·   Cervical Spondylosis
·   Trigeminal Neuralgia
·   Reflex Sympathetic Dystrophy ( RSD)
·   Carpal Tunnel Syndrome ( CTS)

The new interferential/tens Infrex Plus is also reducing the dependency and costs of traditional opioid drugs providing the patient better, safer, and less expensive options.

###

Read the full story at http://www.prweb.com/releases/2009/02/prweb2039394.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New research shows how chronic stress worsens neurodegenerative disease course
2. Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease
3. Study identifies key player in the bodys immune response to chronic stress
4. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
5. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
6. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
7. Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007
8. Methadone and systematic follow-up: the best solution for managing chronic pain
9. NASN Joins Partnership to Fight Chronic Disease
10. Stomach Virus a Culprit in Chronic Fatigue Syndrome
11. Chronic fatigue syndrome linked to stomach virus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chronic Pain Patients Now Have Hope With Carryover Pain Relief Provided By Repeated Interferential Treatments 
(Date:2/18/2017)... , ... February 17, 2017 , ... Butler Mobility invited ... Stannah Stairlift and other Butler products. Ken was impressed with the safety and ... to endorse the product on his show. This endorsement by Ken Matthews can ...
(Date:2/17/2017)... ... 2017 , ... Smiles by Seese is a comprehensive family dental practice ... leads the practice as a skilled and highly credentialed dentist who is qualified to ... patients of all ages with excellence in general, restorative, and cosmetic dentistry . ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Webinar**, Feb. 22, 2017 — 1:30 p.m. – 2:30 p.m. ET, ... be asking before selecting an FDA approval pathway? , How should they ...
(Date:2/17/2017)... ... 2017 , ... Program will serve more than 5,000 kids ... Soccer Foundation announced today that they have awarded nine grants to expand the ... soccer mentoring program, teaches kids the fundamentals of soccer while striving to help ...
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across the nation, Onslow Memorial ... by the Hospital Readmission Reduction Program (HRRP), the return of a patient to the ... across the nation. While many providers are struggling to leverage limited resources and technology, ...
Breaking Medicine News(10 mins):
(Date:2/18/2017)... Research and Markets has announced the addition of the "Contraceptives - ... ... the US, Canada , Japan , ... Latin America , and Rest of World. Annual estimates and forecasts ... analysis is provided for these markets. Market data and analytics are derived ...
(Date:2/17/2017)...  Ethicon, Inc. today announced a definitive agreement ... medical device company that manufactures and markets the ... minimally invasive device for the surgical treatment of ... Ethicon to offer patients a safe and effective ... procedure. 1 This LINX ® ...
(Date:2/17/2017)... 2017 Theravance Biopharma, Inc. (NASDAQ: ... today announced the presentation of positive clinical data ... pan-Janus kinase (JAK) inhibitor designed to be intestinally ... the European Crohn,s and Colitis Organization (ECCO). In ... from its completed Phase 1 study of single-ascending ...
Breaking Medicine Technology: